JP2018516266A5 - - Google Patents

Download PDF

Info

Publication number
JP2018516266A5
JP2018516266A5 JP2017561947A JP2017561947A JP2018516266A5 JP 2018516266 A5 JP2018516266 A5 JP 2018516266A5 JP 2017561947 A JP2017561947 A JP 2017561947A JP 2017561947 A JP2017561947 A JP 2017561947A JP 2018516266 A5 JP2018516266 A5 JP 2018516266A5
Authority
JP
Japan
Prior art keywords
celecoxib
pain
composition
pharmaceutical composition
liquid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017561947A
Other languages
English (en)
Japanese (ja)
Other versions
JP6605047B2 (ja
JP2018516266A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/034844 external-priority patent/WO2016191744A1/en
Publication of JP2018516266A publication Critical patent/JP2018516266A/ja
Publication of JP2018516266A5 publication Critical patent/JP2018516266A5/ja
Application granted granted Critical
Publication of JP6605047B2 publication Critical patent/JP6605047B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017561947A 2015-05-28 2016-05-27 疼痛治療のためのセレコキシブの経口用組成物 Active JP6605047B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2682/CHE/2015 2015-05-28
IN2682CH2015 2015-05-28
IN6614/CHE/2015 2015-12-10
IN6614CH2015 2015-12-10
PCT/US2016/034844 WO2016191744A1 (en) 2015-05-28 2016-05-27 Oral composition of celecoxib for treatment of pain

Publications (3)

Publication Number Publication Date
JP2018516266A JP2018516266A (ja) 2018-06-21
JP2018516266A5 true JP2018516266A5 (enExample) 2018-08-30
JP6605047B2 JP6605047B2 (ja) 2019-11-13

Family

ID=56137539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017561947A Active JP6605047B2 (ja) 2015-05-28 2016-05-27 疼痛治療のためのセレコキシブの経口用組成物

Country Status (12)

Country Link
US (7) US9572819B2 (enExample)
EP (1) EP3302429A1 (enExample)
JP (1) JP6605047B2 (enExample)
KR (1) KR101994129B1 (enExample)
CN (3) CN107847437B (enExample)
AU (2) AU2016267685A1 (enExample)
CA (1) CA2987272C (enExample)
EA (1) EA038013B1 (enExample)
MX (1) MX384044B (enExample)
NZ (1) NZ737561A (enExample)
RU (1) RU2708254C2 (enExample)
WO (1) WO2016191744A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX384044B (es) * 2015-05-28 2025-03-14 Dr Reddy´S Laboratories Ltd Composicion oral de celecoxib para tratamiento de dolor.
AU2017275844A1 (en) 2016-05-27 2019-01-17 Dr. Reddy's Laboratories Ltd. Oral composition of celecoxib for treatment of pain
US11108393B2 (en) 2018-01-05 2021-08-31 Darfon Electronics Corp. Optical keyswitch triggered by support mechanism having at least one rotatable frame enable a protrusion to move along with a key cap
US11770123B2 (en) 2018-01-05 2023-09-26 Darfon Electronics Corp. Optical keyswitch comprising a keycap having a light transmission area and a keycap projection area projected on a circuit board
WO2022144590A1 (en) 2020-12-28 2022-07-07 Dr. Reddy's Laboratories Ltd. Celecoxib for treating pain
US11721500B2 (en) 2021-04-07 2023-08-08 Darfon Electronics Corp. Keyswitch assembly and support mechanism thereof
US11735379B2 (en) 2021-04-07 2023-08-22 Darfon Electronics Corp. Keyswitch assembly

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580860B2 (en) 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Method of manufacturing solid dispersion
US5466823A (en) 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
RO118291B1 (ro) 1993-11-30 2003-04-30 Searle & Co Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5993858A (en) 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
AU728695B2 (en) 1997-07-29 2001-01-18 Boehringer Ingelheim International Gmbh Self-emulsifying formulation for lipophilic compounds
AU5486899A (en) 1998-08-13 2000-03-06 Cima Labs, Inc. Microemulsions as solid dosage forms for oral administration
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
EP1135150B1 (en) 1998-12-11 2012-10-17 Tris Pharma, Inc. Self-emulsifying compositions for drugs poorly soluble in water
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6057289A (en) 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
CO5261556A1 (es) * 1999-12-08 2003-03-31 Pharmacia Corp Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico
WO2001042221A1 (en) * 1999-12-08 2001-06-14 Pharmacia Corporation Solid-state form of celecoxib having enhanced bioavailability
EP1274425A1 (en) * 2000-04-18 2003-01-15 Pharmacia Corporation Rapid-onset formulation of a selective cyclooxigenase-2 inhibitor
US20080009467A1 (en) * 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
EA006759B1 (ru) 2000-10-31 2006-04-28 Бёрингер Ингельхайм Фармасьютиклз, Инк. Пероральные лекарственные самоэмульгирующиеся композиции ингибиторов протеазы из класса пиранонов
PL368850A1 (en) 2001-06-21 2005-04-04 Pfizer Products Inc. Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
US20030073609A1 (en) * 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
WO2004000284A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
IL164163A0 (en) 2002-04-09 2005-12-18 Pharmacia Corp Process for preparing a finely self-emulsifiable pharmaceutical composition
US6689382B2 (en) * 2002-05-15 2004-02-10 Procaps S.A. Soft shell gelatin capsules containing non-steroidal anti-inflammatories
AU2003295846A1 (en) * 2002-11-26 2004-06-18 Transform Pharmaceuticals, Inc. Pharmaceutical formulations of celcoxib
CA2537029C (en) 2003-11-26 2013-03-12 Likan Liang Micellar systems useful for delivery of lipophilic or hydrophobic compounds
EP2003970A4 (en) 2006-03-28 2012-07-11 Javelin Pharmaceuticals Inc FORMULATIONS OF LOW-DOSEED NON-STEROID INFLAMMATORY INHIBITORS AND BETA-CYCLODEXTRIN
EP1961412A1 (en) 2006-12-27 2008-08-27 LEK Pharmaceuticals D.D. Self-microemulsifying drug delivery systems
WO2008115572A1 (en) 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
EP2222282A1 (en) * 2007-11-15 2010-09-01 Pfizer Products Inc. Dosage forms comprising celecoxib providing both rapid and sustained pain relief
WO2010150144A2 (en) * 2009-06-25 2010-12-29 Wockhardt Research Centre Low dose pharmaceutical compositions of celecoxib
EP2311446A1 (en) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising Tramadol and Celecoxib in the treatment of pain
EP2340819A1 (en) * 2009-12-23 2011-07-06 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising venlafaxine and celecoxib in the treatment of pain
US9415035B2 (en) * 2010-09-17 2016-08-16 Maine Natural Health Company, Inc. Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
KR101413846B1 (ko) * 2012-04-12 2014-06-30 주식회사 종근당 ４－［５－（４－메칠페닐）－３－（트리플루오로메칠）피라졸－１－일］벤젠술폰아미드 화합물 함유 액상 조성물
KR101455901B1 (ko) * 2012-05-04 2014-11-03 성균관대학교산학협력단 세레콕시브 및 폴록사머를 포함하는 공융 혼합물
KR20140100170A (ko) 2013-02-05 2014-08-14 에스케이케미칼주식회사 셀레콕시브 경구투여용 조성물
MX349193B (es) 2013-08-27 2017-07-18 Alparis Sa De Cv Capsula con contenido liquido con un antiinflamatorio.
RU2016136430A (ru) * 2014-02-11 2018-03-15 Др. Редди'С Лабораторис Лтд. Парентеральные композиции целекоксиба
US20150342893A1 (en) * 2014-05-29 2015-12-03 Sigmoid Pharma Limited Celecoxib formulations useful for treating colorectal cancer
MX384044B (es) * 2015-05-28 2025-03-14 Dr Reddy´S Laboratories Ltd Composicion oral de celecoxib para tratamiento de dolor.
WO2016196085A1 (en) * 2015-05-29 2016-12-08 Kiel Laboratories, Inc. Liquid formulations of celecoxib for oral administration

Similar Documents

Publication Publication Date Title
JP2018516266A5 (enExample)
RU2720204C1 (ru) Сублингвальная фармацевтическая композиция эдаравона и (+)-2-борнеола
JP7602324B2 (ja) 重水素化ドンペリドン組成物、方法、及び調製
BRPI0608853B1 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
ES2364538T3 (es) Combinación farmacéutica de alisquireno y valsartán.
CN105073127A (zh) 用于治疗肠纤维化的口服类固醇制剂
JP2011500552A (ja) 胃腸障害を処置するための医薬用組み合わせおよび組成物
JP2018513171A (ja) Ｌ−オルニチンフェニルアセテート製剤
ES3036967T3 (en) Delayed release deferiprone tablets and methods of using the same
TW201501730A (zh) 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
JP6605047B2 (ja) 疼痛治療のためのセレコキシブの経口用組成物
CN108348475A (zh) 处于液体剂型的多层药学活性化合物释放微粒
BR112020026266A2 (pt) Formulações de 5-hidroxitriptofano (5-htp) para melhor biodisponibilidade para várias indicações
WO2017093444A1 (en) Compositions for oral administration in the treatment of inflammatory bowel disease
TWI327913B (en) Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
TW201739455A (zh) 菸鹼醯胺的口服醫藥組成物
BR112014013374B1 (pt) Comprimidos de acamprosato e usos de acamprosato referência cruzada aos pedidos relacionados
JP7636489B2 (ja) ロキソプロフェン又はその塩及びビタミンｂ１２類を含有する経口用医薬組成物
JPWO2002066030A1 (ja) ジクロフェナクとオルノプロスチルからなる医薬組成物
KR101383430B1 (ko) 새로운 조합의 구강내 속붕해 필름형성 조성물 및 ｐｄｅ５ 저해제가 함유된 구강내 속붕해 필름제제
AU2022383315B2 (en) Solid dispersion, preparation method therefor, and solid formulation containing same
WO2010087358A1 (ja) 新規組成物
TR201801650T1 (tr) Kontrollü salim propi̇veri̇n formülasyonlari
CN105209043B (zh) 噻唑并嘧啶酮用于治疗炎症性肠病的应用
WO2013157584A1 (ja) カプセル剤